ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/TERT-BUTYL N-[(1S)-1-(BENZYLCARBAMOYL)-2-HYDROXYETHYL]CARBAMATE
C15H22N2O4
294.35 g/mol
Pharmaceutical IntermediateWarning

TERT-BUTYL N-[(1S)-1-(BENZYLCARBAMOYL)-2-HYDROXYETHYL]CARBAMATE

CAS141108-78-3EC689-217-5
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a protected serine derivative used as an intermediate in peptide synthesis. It features a tert-butoxycarbonyl (Boc) protecting group on the amino terminus and a benzylamide group, making it suitable for selective incorporation into peptide chains.

peptide synthesis intermediate

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.79

(R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate

CAS880468-89-3

pharmaceutical intermediate

ApplicationSame Use

N-Boc-N'-Fmoc-L-ornithine

CAS150828-96-9

pharmaceutical intermediate

ApplicationSame Use

(S)-2-((S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-METHYLBUTANAMIDO)-5-UREIDOPENTANOIC ACID

CAS159858-21-6

pharmaceutical intermediate

ApplicationSame Use

(23S,50S)-50-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid

CAS1662688-20-1

pharmaceutical intermediate

ApplicationSame Use

(S)-22-(tert-Butoxycarbonyl)-45,45-dimethyl-10,19,24,43-tetraoxo-3,6,12,15,44-pentaoxa-9,18,23-triazahexatetracontanoic acid

CAS1188328-37-1

pharmaceutical intermediate

ReferenceSame Category

(R)-Tetrahydropapaverine N-acetyl-L-leucinate

CAS141109-12-8

pharmaceutical intermediate

ReferenceSame Category

(1S,4R)-4-[(2,5-Diamino-6-chloro-4-pyrimidinyl)amino]-2-cyclopentene-1-methanol

CAS141271-12-7

pharmaceutical intermediate

ReferenceSame Category

11,12-Dihydro Altrenogest

CAS141299-96-9

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H302Harmful if swallowed
H312Harmful in contact with skin
H332Harmful if inhaled
Identifiers
IUPAC Name

tert-butyl N-[(2S)-1-(benzylamino)-3-hydroxy-1-oxopropan-2-yl]carbamate

InChIKey

CTFYHNRRPGOYJS-LBPRGKRZSA-N

SMILES

CC(C)(C)OC(=O)N[C@@H](CO)C(=O)NCC1=CC=CC=C1

Synonyms (3)
  • Lacosamide Impurity 71

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→